Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

VCT 220

Next Previous
Drug Profile

VCT 220

Alternative Names: CX-11; VCT-220

Latest Information Update: 22 Jan 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Vincentage Pharma
  • Developer Corxel Pharmaceuticals; Vincentage Pharma
  • Class Antihyperglycaemics; Obesity therapies; Small molecules
  • Mechanism of Action Glucagon-like peptide-1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Obesity
  • Phase I Type 2 diabetes mellitus

Most Recent Events

  • 22 Jan 2026 Vincentage Pharma plans a phase I trial in Obesity and Type 2 diabetes mellitus (In volunteers) in China (PO) (NCT07349381)
  • 14 Jan 2026 Corxel Pharmaceuticals plans a phase II trial for Type 2 diabetes mellitus (Treatment-experienced) in US and Poland (PO, Tablet) in February 2026 (NCT07340320)
  • 13 Jan 2026 Vincentage Pharma plans a phase II VICTOR-HTN trial for Hypertension and Obesity in China (PO, Tablet) in March 2026 (NCT07360275)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top